Breast Cancer Society of Canada Grants $350,000 To Precision Oncology Research
May 25, 2022 09:24 ET | The Breast Cancer Society of Canada
SARNIA, Ontario, May 25, 2022 (GLOBE NEWSWIRE) -- The Breast Cancer Society of Canada (BCSC) today announced the recipients of their first-ever Breast Cancer Research request for proposals....
Logo.png
Metastatic Breast Cancer Pipeline Report: Emerging Therapies and Treatment Outlook | DelveInsight
May 24, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USAMetastatic Breast Cancer Pipeline Report: Emerging Therapies and Treatment Outlook | De, May 24, 2022 (GLOBE NEWSWIRE) -- Metastatic Breast Cancer Pipeline Report: Emerging Therapies...
MicrosoftTeams-image (5).png
Breast Cancer Diagnostics Market is Estimated to Rise at a CAGR of 7% during the Forecast Period, notes TMR Study
May 23, 2022 11:30 ET | Transparency Market Research
Albany NY, United States, May 23, 2022 (GLOBE NEWSWIRE) -- Breast cancer diagnostics market projections estimate the value of global market to stand at US$ 4.8 Bn in 2018 and the market is likely to...
researchdrivelogo.jpg
Global Radiation Oncology Market Estimated to Generate $10,679.7 Million and Grow at 7.4% CAGR During the 2020-2027 Timeframe [248-Pages] | Research Dive
May 18, 2022 09:05 ET | Research Dive
New York, USA, May 18, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global radiation oncology market is estimated to generate a revenue of $10,679.7 million by...
Straits Research Pvt Ltd
Global Cancer Stem Cells Market is Expected to Reach USD 5.6 Billion by 2030, at a CAGR of 15.8%: Straits Research
May 11, 2022 12:30 ET | Straits Research
New York, United States, May 11, 2022 (GLOBE NEWSWIRE) -- The Global market for cancer stem cells is expected to grow from $ 1.8 Billion in 2021 to $5.6 Billion by 2030, at a compound annual growth...
arvinas_logoART_lg.jpg
Arvinas Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 05, 2022 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., May 05, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
GMILogo_Vertical-Gradient.png
Radiotherapy Market revenue to cross USD 9.7 Billion by 2028, Says Global Market Insights Inc.
May 04, 2022 04:15 ET | Global Market Insights Inc.
Selbyville, Delaware, May 04, 2022 (GLOBE NEWSWIRE) -- The radiotherapy market value is expected to exceed USD 9.7 billion by 2028, according to a new research report by Global Market Insights Inc....
Asia Breast Cancer Screening Market Report 2022: Market is Expected to Reach $16.5 Billion by 2027 from $10.1 Billion in 2021, Post Recovery from the Pandemic
May 04, 2022 04:13 ET | Research and Markets
Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asia Breast Cancer Screening Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis" report has been...
arvinas_logoART_lg.jpg
Arvinas to Present at Bank of America Securities 2022 Healthcare Conference
May 03, 2022 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., May 03, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Announces Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
April 28, 2022 12:47 ET | Sermonix Pharmaceuticals Inc.
COLUMBUS, Ohio, April 28, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...